Care Property Invest NV (CPINV) Fair Value & Analysis
Real Estate · BE · Market cap €523M
Analysis
Care Property Invest NV (CPINV) currently trades at €12.52, while our model-based Fair Value estimate is €12.72 — implying the stock looks roughly 1.6% undervalued today. We read business quality at 95/100 (high quality), in the Real Estate sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Care Property Invest NV is a Public Regulated Real Estate Company (public RREC) under Belgian law. The Company has been listed on Euronext Brussels for 30 years and invests in high quality healthcare real estate for elderly and disabled people on the European market. Care Property Invest purchases, builds and renovates high quality healthcare real estate (residential care centres, groups of assisted living apartments, residential complexes for people with a disability, etc.), fully tailored to the needs of the end user and then makes it available to solid healthcare operators on the basis of a long-term contract. The Company is developing an international portfolio of healthcare projects, which currently counts 160 projects, spread across Belgium, The Netherlands, Spain and Ireland. The market capitalization of Care Property Invest amounted to approximately 516.5 million euros on 8/06/2026. The Company aims to create a stable share for its shareholders with a low risk profile and a …
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.